Manju Sengar Selected Research

Manju Sengar Research Topics

Disease

16	Neoplasms (Cancer) 02/2024 - 10/2013
6	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2024 - 11/2005
6	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2022 - 05/2014
5	Lymphoma (Lymphomas) 02/2024 - 10/2013
5	Hodgkin Disease (Hodgkin's Disease) 02/2024 - 10/2013
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2023 - 10/2013
3	Invasive Fungal Infections 04/2024 - 01/2020
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2016 - 11/2005
3	Carcinoma (Carcinomatosis) 02/2016 - 10/2010
2	Leukemia 02/2024 - 01/2023
2	Breast Neoplasms (Breast Cancer) 12/2023 - 03/2007
2	Acute Promyelocytic Leukemia 10/2023 - 01/2021
2	Multiple Myeloma 11/2022 - 01/2021
2	COVID-19 01/2022 - 12/2020
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2020 - 01/2019
2	Hematologic Neoplasms (Hematological Malignancy) 01/2020 - 01/2020
2	Nasopharyngeal Carcinoma 01/2016 - 12/2009
1	Mycoses (Diseases, Fungus) 12/2023
1	Febrile Neutropenia 12/2023
1	Neutropenia 12/2023
1	Diarrhea 04/2023
1	Vomiting 04/2023
1	Mucositis 04/2023
1	Tumor Lysis Syndrome 01/2023
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2023
1	Colonic Neoplasms (Colon Cancer) 01/2023
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2023
1	AIDS-Related Lymphoma (Lymphoma, AIDS Related) 01/2023
1	Cardiotoxicity 10/2022
1	Frailty 10/2022
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2022
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 01/2022
1	Lung Injury 10/2021
1	Trisomy (Trisomies) 04/2021
1	Thrombocytopenia (Thrombopenia) 04/2021
1	Fibrosis (Cirrhosis) 04/2021
1	Fever (Fevers) 04/2021
1	Edema (Dropsy) 04/2021
1	POEMS Syndrome (Syndrome, POEMS) 04/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2021
1	Infections 01/2021
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2021
1	Pneumonia (Pneumonitis) 11/2020
1	Pathologic Complete Response 10/2020
1	Hepatitis B 01/2020
1	Hepatitis 01/2020
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2020
1	Lactic Acidosis 01/2020
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 10/2017
1	Squamous Cell Carcinoma of Head and Neck 02/2016
1	Plasmacytoma 06/2015
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2015
1	Lymphopenia (Lymphocytopenia) 12/2014

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 12/2023 - 01/2016
4	Rituximab (Mabthera)FDA Link 01/2023 - 10/2013
3	Biosimilar PharmaceuticalsIBA 01/2023 - 10/2013
3	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2022 - 10/2013
3	Bortezomib (Velcade)FDA Link 01/2021 - 01/2015
2	posaconazole FDA Link 04/2024 - 04/2023
2	Prednisolone (Predate)FDA LinkGeneric 01/2023 - 10/2013
2	Lenalidomide (CC 5013)FDA Link 01/2023 - 01/2021
2	Etoposide (VP 16)FDA LinkGeneric 01/2023 - 10/2022
2	Vinblastine (Vinblastine Sulfate)FDA Link 01/2023 - 10/2021
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023 - 10/2013
2	AnthracyclinesIBA 10/2022 - 01/2021
2	Immunoglobulins (Immunoglobulin)IBA 04/2021 - 06/2015
2	Proteins (Proteins, Gene)FDA Link 04/2021 - 01/2019
1	SuspensionsIBA 04/2023
1	rasburicase (Elitek)FDA Link 01/2023
1	Complement System Proteins (Complement)IBA 01/2023
1	LigandsIBA 01/2023
1	B-Cell Maturation AntigenIBA 11/2022
1	Leucovorin (Folinic Acid)FDA Link 10/2022
1	Cytotoxins (Cytolysins)IBA 10/2021
1	Dacarbazine (DIC)FDA LinkGeneric 10/2021
1	Bleomycin (Blenoxane)FDA LinkGeneric 10/2021
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 04/2021
1	Reticulin (Reticular Fiber)IBA 04/2021
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2021
1	pomalidomideIBA 01/2021
1	Arsenic Trioxide (Trisenox)FDA Link 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Monoclonal AntibodiesIBA 01/2020
1	CytokinesIBA 01/2020
1	Interleukin-9 (Interleukin 9)IBA 01/2020
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2020
1	Hepatitis B Core AntigensIBA 01/2020
1	Anaplastic Lymphoma KinaseIBA 10/2017
1	Phosphotransferases (Kinase)IBA 11/2016
1	DNA (Deoxyribonucleic Acid)IBA 01/2016
1	Dihydrotachysterol (AT 10)IBA 01/2016

Therapy/Procedure

22	Therapeutics 04/2024 - 10/2013
19	Drug Therapy (Chemotherapy) 02/2024 - 12/2009
10	Radiotherapy 02/2024 - 01/2009
2	Immunotherapy 01/2020 - 10/2013
1	Induction Chemotherapy 04/2024
1	Combined Modality Therapy 02/2024
1	Time-to-Treatment 01/2023
1	VAP-cyclo protocol 08/2016
1	Chemoradiotherapy 02/2016